Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Immunology and Allergy ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International Consensus on Antineutrophil Cytoplasmic Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis.Am J Respir Crit Care Med. 2020; 202: 1360-1372
- Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients.Mayo Clin Proc. 1990; 65: 847-856
- Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody.Ryumachi. 1995; 35: 46-55
- Interstitial lung disease in ANCA vasculitis.Autoimmun Rev. 2017; 16: 722-729
- Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.Lung. 2016; 194: 235-242
- Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.Eur Respir J. 2010; 36: 116-121
- Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangiitis in the course of idiopathic pulmonary fibrosis.Respir Med. 2013; 107: 608-615
- Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis.Chest. 2019; 156: 715-723
- Anti-neutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.BMJ Open Respir Res. 2015; 2: e000058
- Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody.BMC Pulm Med. 2021; 21: 88
- Genetically distinct subsets within ANCA-associated vasculitis.N Engl J Med. 2012; 367: 214-223
- Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.JAMA Intern Med. 2020; 180: 870-876
- ANCA-associated vasculitis.Nat Rev Dis Primers. 2020; 6: 71https://doi.org/10.1038/s41572-020-0204-y
- Are environmental factors important in primary systemic vasculitis? A case-control study.Arthritis Rheum. 2003; 48: 814-823
- Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.Rheumatology. 2011; 50: 1916-1920
- Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.Mod Rheumatol. 2016; 26: 730-737
- The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.Arthritis Rheum. 2017; 69: 2338-2350
- Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.Rheumatology. 2007; 46: 1329-1337
- A common MUC5B promoter polymorphism and pulmonary fibrosis.N Engl J Med. 2011; 364: 1503-1512
- Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.Thorax. 2013; 68: 436-441
- MUC5B and Idiopathic Pulmonary Fibrosis.Ann Am Thorac Soc. 2015; 12: S193-S199
- Ann Rheum Dis. 2019; 78: 1144-1146
- Antimyeloperoxidase-associated lung disease. An experimental model.Am J Respir Crit Care Med. 1999; 160: 987-994
- The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis.Eur Respir J. 2011; 37: 1503-1513
- Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.Blood. 2011; 117: 953-959
- Cellular Mechanisms of NETosis.Annu Rev Cell Dev Biol. 2020 Oct 6; 36: 191-218
- Neutrophil extracellular traps promote differentiation and function of fibroblasts.J Pathol. 2014; 233: 294-307
- Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway.Am J Respir Cell Mol Biol. 2006; 35: 407-414
- NET balancing: a problem in inflammatory lung diseases.Front Immunol. 2013 Jan 24; 4: 1
- Rare diseases bullet 10: Small vessel vasculitis of the lung.Thorax. 2000; 55: 502-510
- Pulmonary capillaritis.Semin Respir Crit Care Med. 2004; 25: 547-555
- Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease.Chest. 1998; 113: 1609-1615
- Alveolar Hemorrhage in Vasculitis (Primary and Secondary).Semin Respir Crit Care Med. 2018; 39: 482-493
- Pulmonary renal syndrome: a 4-year, single-center experience.Am J Kidney Dis. 2002; 39: 42-47
- Idiopathic pulmonary hemosiderosis: A state of the art review.Respir Med. 2021; 176: 106234
- The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis.Am J Clin Pathol. 2003; 119: 556-567
- Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.Rheumatology. 2011; 50: 2035-2043
- Thoracic manifestation of myeloperoxidase/antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients.J Comput Assist Tomogr. 2004; 28: 710-716
- Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients.Breathe. 2020; 16: 190321
- Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.Sarcoidosis Vasc Diffuse Lung Dis. 2019; 36: 195-201
- Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.J Clin Rheumatol. 2021; 27: 324-330
- A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China.BMC Pulm Med. 2014; 14: 8
- Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis.Eur Respir J. 2012; 40: 505-507
- Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema.Respir Med Case Rep. 2015; 15: 128-132
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Am J Respir Crit Care Med. 2022; 205: e18-e47
- Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.BMC Pulm Med. 2019; 19: 194
- Interstitial lung disease and microscopic polyangiitis in Chilean patients.Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37: 37-42
- Chest High-Resolution CT Findings of Microscopic Polyangiitis: A Japanese First Nationwide Prospective Cohort Study.AJR Am J Roentgenol. 2019; 213: 104-114
- Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital-Based Japanese Patients.Arthritis Rheumatol. 2016; 68: 713-723
- Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features, and mortality.Rheumatology. 2022; keac339 ([published online ahead of print, 2022 Jun 14])
- Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.Medicine (Baltim). 2014; 93 (Published correction appears in Medicine (Baltimore)): 340-349
- Organizing pneumonia associated with myeloperoxidase anti-neutrophil cytoplasmic antibody.Respirol Case Rep. 2015; 3: 122-124
- Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report.Respir Med Case Rep. 2020; 31: 101294
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Annals of the.Rheumatic Diseases. 2016; 75: 1583-1594
- Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature.Ann Rheum Dis. 2009; 68: 404-407
- Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.Rheumatol Int. 2021; 41: 1641-1650
- Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.BMC Pulm Med. 2019; 19: 113
- Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.N Engl J Med. 2012; 366: 1968-1977
- New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?.Curr Opin Pulm Med. 2019; 25: 442-449
- Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.Lancet Respir Med. 2020; 8: 453-460
- Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.Lancet Respir Med. 2021; 9: 476-486
- Current perspective of progressive-fibrosing interstitial lung disease.Respir Investig. 2022; 60: 503-509
- Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases.Ann Am Thorac Soc. 2019; 16: 580-588
- Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.J Clin Med. 2022; 11: 3835
- Impact of interstitial lung disease on mortality in ANCA-associated vasculitis: A systematic literature review and meta-analysis.Chron Respir Dis. 2021; 18 (1479973121994562)
- Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.Chest. 2021; 159: 2334-2345
Article info
Publication history
Published online: March 03, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
